Jälgige meid
EE
EE

Üks Life4me+ peamiseid eesmärke on uute HIVi- ja muude sugulisel teel levivate nakkuste juhtumite, nagu ka C-hepatiiti ja tuberkuloosi nakatumise ennetamine.

Nutirakendus aitab luua kontakti arstide ja HIV positiivsete inimeste vahel. Nutirakendus aitab mugavalt organiseerida ravimite võtmise aegu, seadistada ainult Teile arusaadavad ja personaalseid meeldetuletusi, võimaldab saada arstilt tagasisidet ning panna aega vastuvõtule või analüüsidele.

Kõik uudised

Arhiiv

✕
3 aprill 2017
4314
U. S. National HIV Poetry Writing Month

U. S. National HIV Poetry Writing Month

NaPoWriMo website launches its April campaign "Write a poem about HIV/AIDS."
3 aprill 2017
3961
Best Practices for Indigenous Communities On HIV, Privacy and Confidentiality

Best Practices for Indigenous Communities On HIV, Privacy and Confidentiality

You can find interesting this new guide issued by Canadian HIV/AIDS Legal Network and Canadian Aboriginal AIDS Network (CAAN) for rural indigenous communities.
3 aprill 2017
3739
A Step Forward Towards HIV vaccine: A Novel 'On/Off' Switch

A Step Forward Towards HIV vaccine: A Novel 'On/Off' Switch

By engineering an on/off switch into a weakened form of HIV, University of Nebraska-Lincoln researchers have enhanced the safety and effectiveness of a potential vaccine for HIV.
31 märts 2017
5664
Britain's HIV Charities Ask The NHS #WhereIsPrEP?

Britain's HIV Charities Ask The NHS #WhereIsPrEP?

#Britain's leading HIV organisations have blamed NHS England for the protraction in providing the prevention medicine, despite 17 people a day contracting the virus. WhereIsPrEP United4PreP PreP
31 märts 2017
5950
UNAIDS Believes In African Pharma

UNAIDS Believes In African Pharma

#UNAIDS has been inspiring the local manufacturing of antiretroviral medicines in Africa, the continent with the highest HIV burden. In Western and Central Africa, three out four people living with HIV do not have access to treatment.
30 märts 2017
5811
Inovio Receives NIH Grant To Evaluate HIV Immunotherapy Ability To End Lifetime Of Drug Therapy

Inovio Receives NIH Grant To Evaluate HIV Immunotherapy Ability To End Lifetime Of Drug Therapy

A $6.95 million grant to develop a therapy using Inovio’s PENNVAX-GP with the aim of attaining long-term HIV remission in the absence of antiviral drugs received by Inovio Pharmaceuticals, Inc. and its academic and industry collaborators.
30 märts 2017
5441
Nurse-led Intervention Improves Adherence To ART And Is Cost-Effective

Nurse-led Intervention Improves Adherence To ART And Is Cost-Effective

A nurse-led adherence support programme had a significant effect on viral load and was cost-effective according to Dutch ART adherence support study published recently in The Lancet Infectious Diseases. The study being conducted in the Netherlands between 2011 and 2014 has ...
30 märts 2017
5674
HIV Activists Rally At Capitol: 'Important Moment' In History

HIV Activists Rally At Capitol: 'Important Moment' In History

More than 600 activists and associates gathered at the U.S. Capitol on Tuesday to push for HIV funding from their congressional leadership and spread awareness of issues facing people with HIV and AIDS.
29 märts 2017
5454
U. S. White House Document Announces Massive Cut To AIDS Research

U. S. White House Document Announces Massive Cut To AIDS Research

According to a new White House document distributed to congressional appropriators, Trump is calling for a $1.23 billion reduction in funding to the National Institutes of Health, a major biomedical research facility under the Department of Health and Human Services (HHS). Of ...
29 märts 2017
5709
Australia Cuts Prescription Prices Across Therapeutic Areas

Australia Cuts Prescription Prices Across Therapeutic Areas

Drugs to treat diseases and illnesses like HIV, breast cancer, mental health, eczema, psoriasis and Parkinson’s disease will have prices slashed in a bid to ease the cost of living pressures for millions of Australians. More than 1100 medicines will have their prices cut ...
Kasutusmugavuse parendamiseks rakendab veebileht küpsiseid.
Lehel mis tahes nuppu klõpsates nõustute küpsiste kasutamisega.